VETOQUINOL SA (VETO.PA) Stock Price, Forecast & Analysis
EPA:VETO • FR0004186856
VETO.PA Key Statistics, Chart & Performance
The current stock price of VETO.PA is 89.75 EUR. In the past month the price increased by 4.97%. In the past year, price increased by 21.45%.
VETO.PA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to VETO.PA. When comparing the yearly performance of all stocks, VETO.PA is one of the better performing stocks in the market, outperforming 84.9% of all stocks.
VETO.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to VETO.PA. While VETO.PA has a great health rating, its profitability is only average at the moment.
VETO.PA Financial Highlights
Over the last trailing twelve months VETO.PA reported a non-GAAP Earnings per Share(EPS) of 5.04. The EPS increased by 26.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.28% | ||
| ROA | 8.28% | ||
| ROE | 10.59% | ||
| Debt/Equity | 0.02 |
VETO.PA Forecast & Estimates
11 analysts have analysed VETO.PA and the average price target is 92.41 EUR. This implies a price increase of 2.97% is expected in the next year compared to the current price of 89.75.
VETO.PA Ownership
VETO.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SAN | SANOFI | 9.36 | 199.406B | ||
| SNW | SANOFI | 9.76 | 199.357B | ||
| 1SAN | SANOFI | 9.76 | 199.188B | ||
| MRK | MERCK KGAA | 14.59 | 54.5B | ||
| 1MRK | MERCK KGAA | 14.2 | 53.065B | ||
| UCB | UCB SA | 26.61 | 51.351B | ||
| UNC | UCB SA | 25.59 | 51.195B | ||
| 1BAYN | BAYER AG-REG | 9.44 | 45.329B | ||
| BAYN | BAYER AG-REG | 9.35 | 45.314B | ||
| IPN | IPSEN | 12.94 | 11.633B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About VETO.PA
Company Profile
Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte and currently employs 2,497 full-time employees. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
Company Info
VETOQUINOL SA
Sainte-Anne 34 rue du Chene, Bp 189, Lure Cedex
Lure BOURGOGNE-FRANCHE-COMTE FR
Employees: 2519
Phone: 33384625555
VETOQUINOL SA / VETO.PA FAQ
What does VETO do?
Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte and currently employs 2,497 full-time employees. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
What is the current price of VETO stock?
The current stock price of VETO.PA is 89.75 EUR. The price increased by 3.04% in the last trading session.
Does VETOQUINOL SA pay dividends?
VETOQUINOL SA (VETO.PA) has a dividend yield of 1.04%. The yearly dividend amount is currently 0.85.
What is the ChartMill technical and fundamental rating of VETO stock?
VETO.PA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Where is VETOQUINOL SA (VETO.PA) stock traded?
VETO.PA stock is listed on the Euronext Paris exchange.
Can you provide the market cap for VETOQUINOL SA?
VETOQUINOL SA (VETO.PA) has a market capitalization of 1.07B EUR. This makes VETO.PA a Small Cap stock.
When does VETOQUINOL SA (VETO.PA) report earnings?
VETOQUINOL SA (VETO.PA) will report earnings on 2026-03-18, after the market close.